• On February 24, a federal judge struck down the Maine Pharmacy Act, which had allowed Maine residents to buy and import prescription drugs from pharmacies outside of the United States. U.S. District Court Judge Nancy Torreson ruled that Maine’s law circumvented federal law, which prohibits Americans from importing drugs through foreign pharmacies. The ruling recognized that the federal government has sole jurisdiction to regulate drugs and their importation. This ruling is a great victory. Although such drugs are often cheaper, they lack safety and efficacy controls of FDA-approved and inspected drugs. Importing foreign medications exposes American patients to dangerous counterfeits

    read more →
  • Border-state lawmakers have introduced legislation in Congress that would allow Americans to import prescription drugs from Canada in hopes of driving down drug prices. Aimed Alliance believes the Safe and Affordable Drugs from Canada Act of 2015 (S.122) raises serious concerns about the safety of medications being imported, which are not reviewed for safety or approved by the Food and Drug Administration (FDA) and can have potentially significant health consequences. While S. 122 permits importation of medications from an “approved Canadian pharmacy,” half the shipments seized by U.S. government officials from websites claiming to be Canadian pharmacies in fact came

    read more →
  • Yesterday, Therapeutic Advances in Drug Safety published Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, authored by Aimed Alliance’s Director of Public Policy, Stacey L. Worthy. The article evaluates abuse-deterrent formulations (ADFs) as a method to reduce prescription drug abuse while ensuring access to vital medications for individuals with legitimate need; assesses the pros and cons of ADFs and the current state of ADF adoption in the market; and develops policy recommendations to transition the market to ADFs. Read the article in its entirety here.

    read more →